|Mr. Scott C. Durbin||CEO & Director||635.05k||N/A||1969|
|Mr. Jim B. Robbins||Sr. VP of Fin. & Admin. and Principal Accounting & Financial Officer||350.75k||N/A||1964|
|Ms. Debora A. Jorn M.B.A.||Sr. Advisor to the CEO & Director||35k||N/A||1958|
|Mr. Martin Kerber P.E.||VP of Research, Devel. & Operations||N/A||N/A||N/A|
|Ms. Jeannie Swindle||Sr. Director of Corp. Communications||N/A||N/A||N/A|
|Mr. Jeff Sinclair||VP of International Sales||N/A||N/A||N/A|
|Mr. Gary Kaiser||VP of Global Marketing||N/A||N/A||N/A|
|Ms. Lori McMillan||VP of HR||N/A||N/A||N/A|
|Ms. Suzon D. Lommel||Sr. VP of Regulatory & Quality Affairs||N/A||N/A||1958|
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. The company was founded in 2005 and is headquartered in Englewood, Colorado.
Viveve Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.